De Becker Farmaceutica

Antwerpen ·KBO/BCE: BE 1006.778.737

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	4.2%	37.4%	better than 11% of 1415 sector peers
Net result	€37k	€45k	better than 47% of 1414 sector peers
Equity	€42k	€365k	better than 17% of 1415 sector peers
Gross operating margin	€73k	€65k	better than 53% of 1413 sector peers
Total assets	€998k	€1.41M	better than 42% of 1415 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€998k
Fixed assets	21/28	€955k
Financial fixed assets	28	€955k
Current assets	29/58	€43k
Cash & bank	54/58	€42k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€998k
Equity	10/15	€42k
Contributions / capital	10/11	€5k
Reserves	13	€37k
Amounts payable	17/49	€956k
Amounts payable after one year	17	€765k
Amounts payable within one year	42/48	€191k
Trade debts payable within one year	44	€513
Income statement
Gross operating margin	9900	€73k
Operating result	9901	€73k
Financial charges	65	€22k
Result before taxes	9903	€50k
Income taxes	67/77	€14k
Net result for the period	9904	€37k
Result to be appropriated	9905	€37k

Legal nameNL	De Becker Farmaceutica
AbbreviationNL	DBF

Summary